Li-Fen Lee Is Building a Biotech Around What the Immune System Misses

After two decades inside immunology labs and drug-discovery groups, Li-Fen Lee founded Apeximmune to search for the immune system’s overlooked brakes - then turn those discoveries into antibody medicines.